Health • April 3, 2026
Breakthrough ALS study launches as drug aims to slow disease progression
Originally published on Fox News Health
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
Originally published on Fox News Health.
More good news
- A little kid snuck into his older brother’s game and somehow ended up getting his very first red card.
- Fairies 🧚
- (OC) I won the parents lottery! They are soon celebrating their 58th wedding anniversary. They always put me and my late brother Brett first. They've given me everything, even when I didn't deserve it. Tragedy only made them closer, and the good times far outweigh the bad. I love them so much!
- The hat my wife and kids handmade me for Father's Day